BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

158 related articles for article (PubMed ID: 36249907)

  • 21. Rare case of remission of a patient with small cell carcinoma of the ovary, hypercalcaemic type (SCCOHT) stage IV: Case report.
    Mathey MP; de Jolinière JB; Major A; Conrad B; Khomsi F; Betticher D; Devouassoux M; Feki A
    Int J Surg Case Rep; 2020; 66():398-403. PubMed ID: 31978720
    [TBL] [Abstract][Full Text] [Related]  

  • 22. [Small cell carcinoma of ovary, hypercalcemic type: analysis of clinicopathologic characteristics and the diagnostic utility of loss expression of SMARCA4 protein].
    Wang L; Tan C; Tu X; Zhang Y; Li X; Chang B
    Zhonghua Bing Li Xue Za Zhi; 2015 Dec; 44(12):859-63. PubMed ID: 26888501
    [TBL] [Abstract][Full Text] [Related]  

  • 23. SMARCA4 inactivating mutations cause concomitant Coffin-Siris syndrome, microphthalmia and small-cell carcinoma of the ovary hypercalcaemic type.
    Errichiello E; Mustafa N; Vetro A; Notarangelo LD; de Jonge H; Rinaldi B; Vergani D; Giglio SR; Morbini P; Zuffardi O
    J Pathol; 2017 Sep; 243(1):9-15. PubMed ID: 28608987
    [TBL] [Abstract][Full Text] [Related]  

  • 24. Small Cell Carcinoma of the Ovary, Hypercalcemic Type: Report of a Bilateral Case in a Teenager Associated with SMARCA4 Germline Mutation.
    Lavrut PM; Le Loarer F; Normand C; Grosos C; Dubois R; Buenerd A; Conter C; Dijoud F; Blay JY; Collardeau-Frachon S
    Pediatr Dev Pathol; 2016; 19(1):56-60. PubMed ID: 26230154
    [TBL] [Abstract][Full Text] [Related]  

  • 25. Case Report: A Durable Response to Camrelizumab and Apatinib Combination Therapy in a Heavily Treated Small Cell Carcinoma of the Ovary, Hypercalcemic Type.
    Li G; Jiang Y
    Front Oncol; 2022; 12():916790. PubMed ID: 35903699
    [TBL] [Abstract][Full Text] [Related]  

  • 26. Successful pregnancy following chemotherapy in a survivor of small cell carcinoma of the ovary, hypercalcemic type (SCCOHT): A case report and review of literature.
    Phoolcharoen N; Woodard T; James D; Patel D; Roder S; Holman D; Salcedo M; Frumovitz M; Gershenson D; Schmeler K
    Gynecol Oncol Rep; 2020 May; 32():100576. PubMed ID: 32405521
    [TBL] [Abstract][Full Text] [Related]  

  • 27. Ovarian carcinoma in children with constitutional mutation of SMARCA4: single-family report and literature review.
    Pastorczak A; Krajewska K; Urbanska Z; Szmyd B; Salacinska-Los E; Kobos J; Mlynarski W; Trelinska J
    Fam Cancer; 2021 Oct; 20(4):355-362. PubMed ID: 33907931
    [TBL] [Abstract][Full Text] [Related]  

  • 28. Loss of SMARCA4 Expression Is Both Sensitive and Specific for the Diagnosis of Small Cell Carcinoma of Ovary, Hypercalcemic Type.
    Conlon N; Silva A; Guerra E; Jelinic P; Schlappe BA; Olvera N; Mueller JJ; Tornos C; Jungbluth AA; Young RH; Oliva E; Levine D; Soslow RA
    Am J Surg Pathol; 2016 Mar; 40(3):395-403. PubMed ID: 26645725
    [TBL] [Abstract][Full Text] [Related]  

  • 29. Concomitant loss of SMARCA2 and SMARCA4 expression in small cell carcinoma of the ovary, hypercalcemic type.
    Jelinic P; Schlappe BA; Conlon N; Tseng J; Olvera N; Dao F; Mueller JJ; Hussein Y; Soslow RA; Levine DA
    Mod Pathol; 2016 Jan; 29(1):60-6. PubMed ID: 26564006
    [TBL] [Abstract][Full Text] [Related]  

  • 30. Ponatinib Shows Potent Antitumor Activity in Small Cell Carcinoma of the Ovary Hypercalcemic Type (SCCOHT) through Multikinase Inhibition.
    Lang JD; Hendricks WPD; Orlando KA; Yin H; Kiefer J; Ramos P; Sharma R; Pirrotte P; Raupach EA; Sereduk C; Tang N; Liang WS; Washington M; Facista SJ; Zismann VL; Cousins EM; Major MB; Wang Y; Karnezis AN; Sekulic A; Hass R; Vanderhyden BC; Nair P; Weissman BE; Huntsman DG; Trent JM
    Clin Cancer Res; 2018 Apr; 24(8):1932-1943. PubMed ID: 29440177
    [No Abstract]   [Full Text] [Related]  

  • 31. Identification of Driver Mutations in Rare Cancers: The Role of SMARCA4 in Small Cell Carcinoma of the Ovary, Hypercalcemic Type (SCCOHT).
    Lang JD; Hendricks WPD
    Methods Mol Biol; 2018; 1706():367-379. PubMed ID: 29423809
    [TBL] [Abstract][Full Text] [Related]  

  • 32. Re-expression of SMARCA4/BRG1 in small cell carcinoma of ovary, hypercalcemic type (SCCOHT) promotes an epithelial-like gene signature through an AP-1-dependent mechanism.
    Orlando KA; Douglas AK; Abudu A; Wang Y; Tessier-Cloutier B; Su W; Peters A; Sherman LS; Moore R; Nguyen V; Negri GL; Colborne S; Morin GB; Kommoss F; Lang JD; Hendricks WP; Raupach EA; Pirrotte P; Huntsman DG; Trent JM; Parker JS; Raab JR; Weissman BE
    Elife; 2020 Dec; 9():. PubMed ID: 33355532
    [TBL] [Abstract][Full Text] [Related]  

  • 33. Small-Cell Carcinoma of the Ovary, Hypercalcemic Type-Genetics, New Treatment Targets, and Current Management Guidelines.
    Tischkowitz M; Huang S; Banerjee S; Hague J; Hendricks WPD; Huntsman DG; Lang JD; Orlando KA; Oza AM; Pautier P; Ray-Coquard I; Trent JM; Witcher M; Witkowski L; McCluggage WG; Levine DA; Foulkes WD; Weissman BE
    Clin Cancer Res; 2020 Aug; 26(15):3908-3917. PubMed ID: 32156746
    [TBL] [Abstract][Full Text] [Related]  

  • 34. Dual loss of the SWI/SNF complex ATPases SMARCA4/BRG1 and SMARCA2/BRM is highly sensitive and specific for small cell carcinoma of the ovary, hypercalcaemic type.
    Karnezis AN; Wang Y; Ramos P; Hendricks WP; Oliva E; D'Angelo E; Prat J; Nucci MR; Nielsen TO; Chow C; Leung S; Kommoss F; Kommoss S; Silva A; Ronnett BM; Rabban JT; Bowtell DD; Weissman BE; Trent JM; Gilks CB; Huntsman DG
    J Pathol; 2016 Feb; 238(3):389-400. PubMed ID: 26356327
    [TBL] [Abstract][Full Text] [Related]  

  • 35. Risk reduction for small cell cancer of the ovary, hypercalcemic type in prepubertal patient: A clinical and bioethical perspective.
    Vu JA; Thompson WS; Klinkner DB; Chattha A; Wick M; Case EJ; Collura C; Kumar A
    Gynecol Oncol Rep; 2023 Oct; 49():101261. PubMed ID: 37663174
    [TBL] [Abstract][Full Text] [Related]  

  • 36. Small Cell Carcinoma of the Ovary, Hypercalcemic Type, in a 12-Month-Old Girl.
    Atwi D; Quinton MR; Kiser RM; Pokala HR; Rooms LM; Yu Z
    Pediatr Dev Pathol; 2021; 24(5):493-497. PubMed ID: 34047234
    [TBL] [Abstract][Full Text] [Related]  

  • 37. Small cell carcinoma of the ovary hypercalcemic type (SCCOHT): A rare case after in vitro fertilization (IVF).
    Ghazi A; Ayaz A; Hamid T; Farooq MU; Islam N
    Pak J Med Sci; 2017; 33(1):241-244. PubMed ID: 28367208
    [TBL] [Abstract][Full Text] [Related]  

  • 38. Loss of SMARCA4 (BRG1) protein expression as determined by immunohistochemistry in small-cell carcinoma of the ovary, hypercalcaemic type distinguishes these tumours from their mimics.
    Clarke BA; Witkowski L; Ton Nu TN; Shaw PA; Gilks CB; Huntsman D; Karnezis AN; Sebire N; Lamovec J; Roth LM; Stewart CJ; Hasselblatt M; Foulkes WD; McCluggage WG
    Histopathology; 2016 Nov; 69(5):727-738. PubMed ID: 27100627
    [TBL] [Abstract][Full Text] [Related]  

  • 39. Small Cell Carcinoma of Ovary, Hypercalcemic Type: A Rare Case Report.
    Coşkun Ç; Kurucu N; Usubutun A; Soyer T; Ozcan HN; Çelik Ertaş NB; Kutluk T
    J Pediatr Adolesc Gynecol; 2023 Apr; 36(2):112-115. PubMed ID: 36243275
    [TBL] [Abstract][Full Text] [Related]  

  • 40. Refractory Small Cell Carcinoma of the Ovary - Hypercalcemic Type (SCCOHT) Treated with Romidepsin and Topotecan: A Case Report and Review of the Literature.
    Rao V; Bauer F; Vredenburgh JJ
    Conn Med; 2016 Oct; 80(9):529-532. PubMed ID: 29772136
    [TBL] [Abstract][Full Text] [Related]  

    [Previous]   [Next]    [New Search]
    of 8.